LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | I16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | J05 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Etoposide | 1 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | E13 |
| MCF 10A-H2B-mCherry | Etoposide | 0.031667 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | J16 |
| MCF 10A-H2B-mCherry | Vorinostat | 0.0033333 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | C12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | D12 |
| MCF 10A-H2B-mCherry | Etoposide | 0.01 | 29.92 | 84.90 | 7 | 2237 | 0.0031 | -0.4106 | MN20160318_Q02 | H16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | L05 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | L09 |
| MCF 10A-H2B-mCherry | Taxol | 0.017783 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | D04 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | I19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | N13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | G17 |
| MCF 10A-H2B-mCherry | Taxol | 0.31623 | 59.85 | 27.76 | 19 | 6062 | 0.0031 | -0.0476 | MN20160318_Q01 | M21 |